CHATISY THOMAS: Open Payments
NPI 1912325218 · BATON ROUGE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$502 in 22 payments from 9 companies in 2025. Trend: 2023 $302 · 2024 $479 · 2025 $502
Food & beverage: $502
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 8 | $188 |
| Lilly USA, LLC | 3 | $70 |
| AstraZeneca Pharmaceuticals LP | 3 | $68 |
| ABBVIE INC. | 3 | $56 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $30 |
| Exact Sciences Corporation | 1 | $28 |
| Ardelyx, Inc. | 1 | $27 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $19 |
| Novo Nordisk Inc | 1 | $16 |
Products named: Otezla, BREZTRI, MOUNJARO, VRAYLAR, CAPLYTA, The Cologuard Plus Collection Kit, IBSRELA, Kerendia.
Industry payments across LA — which companies pay providers there.
